Long noncoding RNA regulatory factor X3- antisense RNA 1 promotes non-small cell lung cancer via the microRNA-577/signal transducer and activator of transcription 3 axis

References

• Chen Z, Fillmore CM, Hammerman PS, et al. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014;14(8):535–546.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014;14(8):535–546.
   PubMed Web of Science ®Google Scholar
• Osielska MA, Jagodziński PP. Long noncoding RNA as potential biomarkers in non-small-cell lung cancer: what do we know so far? Biomed Pharmacother. 2018;101:322–333.
   PubMed Web of Science ®Google Scholar
• Taniue K, Akimitsu N. The functions and unique features of lncrnas in cancer development and tumorigenesis. Int J Mol Sci. 2021;22(2):632.
   PubMed Web of Science ®Google Scholar
• Chen J, Wang R, Zhang K, et al. Long noncoding RNAs in non-small cell lung cancer as biomarkers and therapeutic targets. J Cell Mol Med. 2014;18(12):2425–2436.
   PubMed Web of Science ®Google Scholar
• Liu SY, Zhao ZY, Qiao Z, et al. LncRNA PCAT1 interacts with DKC1 to regulate proliferation, invasion and apoptosis in NSCLC cells via the VEGF/AKT/Bcl2/Caspase9 pathway. Cell Transplant. 2021;30:963689720986071.
   PubMed Web of Science ®Google Scholar
• Shen D, Li J, Tao K, et al. Long noncoding RNA MCM3AP antisense RNA 1 promotes non-small cell lung cancer progression through targeting microRNA-195-5p. Bioengineered. 2021 Dec;12(1):3525–3538.
   PubMed Web of Science ®Google Scholar
• Hou M, Wu NN, Yao LL. LncRNA CBR3-AS1 potentiates Wnt/β-catenin signaling to regulate lung adenocarcinoma cells proliferation, migration and invasion. Cancer Cell Int. 2021;21(1):36.
   PubMed Web of Science ®Google Scholar
• Ham J, Jeong D, Park S, et al. Ginsenoside Rg3 and Korean Red Ginseng extract epigenetically regulate the tumor-related long noncoding RNAs RFX3-AS1 and STXBP5-AS1. J Ginseng Res. 2019;43(4):625–634.
   PubMed Web of Science ®Google Scholar
• Mishra PJ. MicroRNAs as promising biomarkers in cancer diagnostics. Biomark Res. 2014;2:19.
   PubMedGoogle Scholar
• Cui D, Feng Y, Qian R. Up-regulation of microRNA miR-101-3p enhances sensitivity to cisplatin via regulation of small interfering RNA (siRNA) Anti-human AGT4D and autophagy in non-small-cell lung carcinoma (NSCLC). Bioengineered. 2021 Dec;12(1):8435–8446.
   PubMed Web of Science ®Google Scholar
• Gong SK, Ying L, Fan YN, et al. Fentanyl inhibits lung cancer viability and invasion via upregulation of miR-331-3p and repression of HDAC5. Onco Targets Ther. 2020;13:13131–13141.
   PubMed Web of Science ®Google Scholar
• Zhang TQ, Li M, Lu HF, et al. Up-Regulation of circEIF6 contributes to pancreatic cancer development through targeting miR-557/ SLC7A11/PI3K/AKT signaling. Cancer Manag Res. 2021;13:247–258.
   PubMed Web of Science ®Google Scholar
• Luo YH, Wu JH, Wu QY, et al. miR-577 regulates TGF-β induced cancer progression through a SDPR-modulated positive-feedback loop with ERK-NF-κB in gastric cancer. Mol Ther. 2019;27(6):1166–1182.
   PubMed Web of Science ®Google Scholar
• Tolomeo M, Cascio A. The multifaced role of STAT3 in cancer and its implication for anticancer therapy. Int J Mol Sci. 2021;22(2):603.
   PubMed Web of Science ®Google Scholar
• Huang XJ, Xiao SS, Zhu XP, et al. miR-196b-5p-mediated downregulation of FAS promotes NSCLC progression by activating IL6-STAT3 signaling. Cell Death Dis. 2020;11(9):785.
   PubMed Web of Science ®Google Scholar
• Yang XB, Gao Y, Liu Q, et al. Zoledronic acid re‑sensitises gefitinib‑resistant lung cancer cells by inhibiting the JAK/STAT3 signalling pathway and reversing epithelial‑mesenchymal transition. Oncol Rep. 2020;45(2):459–468.
   PubMed Web of Science ®Google Scholar
• Zheng QY, Dong H, Mo JS, et al. A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance. Theranostics. 2021;11(2):824–840.
   PubMed Web of Science ®Google Scholar
• Zhang L, Jin C, Yang G, et al. LncRNA WTAPP1 promotes cancer cell invasion and migration in NSCLC by downregulating lncRNA HAND2-AS1. BMC Pulm Med. 2020 May 30;20(1):153. PMID: 32473628; PMCID: PMC7260856.
   PubMed Web of Science ®Google Scholar
• Sun W, Zu Y, Fu X, et al. K nockdown of lncRNA-XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy. Oncol Rep. 2017 Dec;38(6):3347–3354. Epub 2017 Oct 24. PMID: 29130102; PMCID: PMC5783579.
   PubMed Web of Science ®Google Scholar
• Liu J, Yao L, Zhang M, et al. Downregulation of LncRNA-XIST inhibited development of non-small cell lung cancer by activating miR-335/SOD2/ROS signal pathway mediated pyroptotic cell death. Aging (Albany NY). 2019 Sep 25;11(18):7830–7846. Epub 2019 Sep 25. PMID: 31553952; PMCID: PMC6781979.
   PubMedGoogle Scholar
• Jiang K, Zou H. microRNA-20b-5p overexpression combing Pembrolizumab potentiates cancer cells to radiation therapy via repressing programmed death-ligand 1. Bioengineered. 2022 Jan;13(1):917–929. PMID: 34968160; PMCID: PMC8805988.
   PubMed Web of Science ®Google Scholar
• Xie J, Yuan Y, Yao G, et al. Nucleoporin 160 (NUP160) inhibition alleviates diabetic nephropathy by activating autophagy. Bioengineered. 2021;12(1):6390–6402.
   PubMed Web of Science ®Google Scholar
• Huang C, Liu J, He L, et al. The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development. Bioengineered. 2021;12(2):11738–11755.
   PubMed Web of Science ®Google Scholar
• Han B, Ge Y, Cui J, et al. Down-regulation of lncRNA DNAJC3-AS1 inhibits colon cancer via regulating miR-214-3p/LIVIN axis. Bioengineered. 2020;11(1):524–535.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454.
   PubMed Web of Science ®Google Scholar
• Yang F, Ma C, Qiu J, et al. Identification of circRNA_001846 as putative non-small cell lung cancer biomarker. Bioengineered. 2021;12(1):8690–8697.
   PubMed Web of Science ®Google Scholar
• Guo S, Yin Y, Wang Z, et al. lncRNA TUG1 Expression in NSCLC and its clinical significance. Clin Lab. 2020;66(10):10.7754/Clin.Lab.2020.200217.
   Web of Science ®Google Scholar
• Ginn L, Shi L, Montagna M, et al. LncRNAs in non-small-cell lung cancer. Noncoding RNA. 2020;6(3):25.
   PubMed Web of Science ®Google Scholar
• Sun CC, Zhu W, Li SJ, et al. FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway [published correction appears in Genome Med. 2021 Feb 11;13(1):25]. Genome Med. 2020;12(1):77.
   PubMed Web of Science ®Google Scholar
• Sun JY, Xiong YL, Jiang K, et al. Hypoxia-sensitive long noncoding RNA CASC15 promotes lung tumorigenesis by regulating the SOX4/β-catenin axis. J Exp Clin Cancer Res. 2021;40(1):12.
   PubMed Web of Science ®Google Scholar
• Xiao L, Li Y, Zeng XF, et al. Silencing of LOC389641 impairs cell proliferation and induces autophagy via EGFR/MET signaling in lung adenocarcinoma. Aging (Albany NY). 2020;13(2):2539–2552.
   PubMedGoogle Scholar
• Zhu Y, Ma K, Ye Y, et al. Long noncoding RNA LINRIS is up-regulated in non-small cell lung cancer and its silencing inhibits cell proliferation by suppressing microRNA-10a maturation. Bioengineered. 2022 Feb;13(2):4340–4346.
   PubMed Web of Science ®Google Scholar
• Song H, Li H, Ding XS, et al. Long non‑coding RNA FEZF1‑AS1 facilitates non‑small cell lung cancer progression via the ITGA11/miR‑516b‑5p axis. Int J Oncol. 2020;57(6):1333–1347.
   PubMed Web of Science ®Google Scholar
• Ju ZX, Sun B, Bao D, et al. Effect of lncRNA-BLACAT1 on drug resistance of non-small cell lung cancer cells in DDP chemotherapy by regulating cyclin D1 expression. Eur Rev Med Pharmacol Sci. 2020;24(18):9465–9472.
   PubMed Web of Science ®Google Scholar
• Wang RX, Chen CY, Kang WB, et al. SNHG9 was up-regulated in NSCLC and associated with DDP-resistance and poor prognosis of NSCLC patients. Am J Transl Res. 2020;12(8):4456–4466.
   PubMed Web of Science ®Google Scholar
• Li S, Gao M, Li Z, et al. Role of microRNAs in metastasis of non-small cell lung cancer. Front Biosci (Landmark Ed). 2016;21(5):998–1005.
   PubMedGoogle Scholar
• Ahn YH, Ko YH. Diagnostic and Therapeutic Implications of microRNAs in Non-Small Cell Lung Cancer. Int J Mol Sci. 2020;21(22):8782.
   PubMed Web of Science ®Google Scholar
• Yin H, Ma JQ, Chen L, et al. MiR-99a enhances the radiation sensitivity of non-small cell lung cancer by targeting mTOR. Cell Physiol Biochem. 2018;46(2):471–481.
   PubMedGoogle Scholar
• El Founini Y, Chaoui I, Dehbi H, et al. MicroRNAs: key regulators in lung cancer. Microrna. 2021;10(2):109–122.
   PubMedGoogle Scholar
• Liang Z, Xu J, Ma Z, et al. MiR-187 suppresses non-small-cell lung cancer cell proliferation by targeting FGF9. Bioengineered. 2020 Dec;11(1):70–80.
   PubMed Web of Science ®Google Scholar
• Liao J, Shen J, Leng Q, et al. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC). Thorac Cancer. 2020;11(3):762–768.
   PubMed Web of Science ®Google Scholar
• Ding H, Wen W, Ding Q, et al. Diagnostic valuation of serum miR-184 and miR-191 in patients with non-small-cell lung cancer. Cancer Control. 2020;27(1):1073274820964783.
   Web of Science ®Google Scholar
• Yin CG, Mou QJ, Pan XT, et al. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25. Thorac Cancer. 2018;9(4):472–479.
   PubMed Web of Science ®Google Scholar
• Xue KC, Hu DD, Zhao L, et al. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2. Eur Rev Med Pharmacol Sci. 2017;21(17):3794–3800.
   PubMed Web of Science ®Google Scholar
• Li T, Xing Y, Yang F, et al. LncRNA SNHG3 sponges miR-577 to up-regulate SMURF1 expression in prostate cancer. Cancer Med. 2020;9(11):3852–3862.
   PubMed Web of Science ®Google Scholar
• Mohrherr J, Uras IZ, Moll HP, et al. STAT3: versatile functions in non-small cell lung cancer. Cancers (Basel). 2020;12(5):1107.
   PubMed Web of Science ®Google Scholar
• Lin Y, He ZQ, Ye JZ, et al. Progress in understanding the IL-6/STAT3 pathway in colorectal cancer. Onco Targets Ther. 2020;13:13023–13032.
   PubMed Web of Science ®Google Scholar
• Wang RY, ZHang D, Sun KW, et al. Amygdalin promotes the activity of T cells to suppress the progression of HBV-related hepatocellular carcinoma via the JAK2/STAT3 signaling pathway. BMC Infect Dis. 2021;21(1):56.
   PubMed Web of Science ®Google Scholar
• Yu FS, Qiao PP, Yin GJ, et al. RHPN2 promotes malignant cell behaviours in ovarian cancer by activating STAT3 signalling. Onco Targets Ther. 2020;13:11517–11527.
   PubMed Web of Science ®Google Scholar
• An YX, Shang YJ, Xu ZW, et al. STAT3-induced long noncoding RNA LINC00668 promotes migration and invasion of non-small cell lung cancer via the miR-193a/KLF7 axis. Biomed Pharmacother. 2019;116:109023.
   PubMed Web of Science ®Google Scholar
• Li ZY, Zhang ZZ, Bi H, et al. MicroRNA‑4500 suppresses tumor progression in non‑small cell lung cancer by regulating STAT3. Mol Med Rep. 2019;20(6):4973–4983.
   PubMed Web of Science ®Google Scholar
• Chen B, Ling CH. Long noncoding RNA AK027294 acts as an oncogene in non-small cell lung cancer by up-regulating STAT3. Eur Rev Med Pharmacol Sci. 2019;23(3):1102–1107.
   PubMed Web of Science ®Google Scholar
• Peng W, He D, Shan B, et al. LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regul.
   Google Scholar